Profil
Derek T.
Chalmers is the founder who has founded two companies.
He founded Arena Pharmaceuticals, Inc. in 1997 and served as Director until 2004.
He also founded CARA Therapeutics, Inc. in 2004 and served as President, Chief Executive Officer & Director until 2021.
Dr. Chalmers also worked as a Group Leader at Neurocrine Biosciences, Inc. Dr. Chalmers received his undergraduate and doctorate degrees from the University of Glasgow.
Anciens postes connus de Derek T. Chalmers
| Sociétés | Poste | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Founder | 08/11/2021 |
| ARENA PHARMACEUTICALS | Founder | 01/05/2004 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Derek T. Chalmers
| University of Glasgow | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
